Covid-19, treatment evolution

After a setback in July, pharmaceutical giant Roche can now claim positive results in the fight against the Covid-19 pandemic. Its anti-inflammatory Actemra/Roactemra (tocilizumab) is said to reduce the need for respirators in hospitalized patients.